Profile
Cynthia Pussinen worked at Actinium Pharmaceuticals, Inc. as Executive Vice President-Technical Development.
Ms. Pussinen worked at Spark Therapeutics, Inc. as Chief Technical Officer from 2021 to 2022.
Ms. Pussinen worked at Sernova Biotherapeutics, Inc. as Chief Executive Officer & Director from 2023 to 2024.
Ms. Pussinen completed undergraduate education at the University of Connecticut and graduate education at Rensselaer Polytechnic Institute.
Former positions of Cynthia Pussinen
| Companies | Position | End |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Chief Executive Officer | 2024-08-11 |
| SPARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-11-30 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Cynthia Pussinen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
- Stock Market
- Insiders
- Cynthia Pussinen
















